Shares of Rocket Lab USA slid 7.3% to $62.05 on July 28, one day after surging roughly 5% on news of the company's largest contract ever — a $266 million missile defense deal with the U.S. Space Force. No new negative surfaced. The reversal looks like classic profit-taking in a stock that has been cut nearly in half from its early-July peak near $100, leaving investors to decide whether the defense windfall changes the math or merely softened the landing.

  • The Contract Is Big, but the Cash Arrives Slowly

The deal covers 12 suborbital launches, with options for six more , running through 2028 as a firm-fixed-price agreement.

About $112 million is already funded from fiscal 2025 research accounts , which reduces cancellation risk. Still, the first launch is not expected until the end of 2026 at the earliest, so the revenue will arrive gradually. Against Q1 quarterly revenue of $200 million, $266 million spread over two-plus years is meaningful — but not transformational on its own.

  • A Bigger Pipeline Sits Behind This Deal

The Space Force just tripled the NSSL Phase 3 Lane 1 contract ceiling from $5.6 billion to $17 billion , a program under which Rocket Lab and SpaceX are among seven companies eligible to compete for future launch orders. Winning a slot doesn't guarantee more work, but it opens a door to billions in government launch spending through 2029 — a pipeline that could dwarf any single contract.

  • The Stock Has Already Priced In a Lot of Growth At $62.05, Rocket Lab carries a market cap of roughly $37 billion . The company is still deep in the red, with net income around negative $45 million and EBITDA roughly negative $30 million last quarter.

Piper Sandler initiated coverage at Neutral with an $83 target, flagging rich valuation versus SpaceX. Shareholders are betting on a future where Rocket Lab's new medium-lift rocket and defense contracts close the gap — but each stumble reminds the market that gap is wide.

  • Execution Through Earnings Will Set the Tone

Rocket Lab's next earnings report is due August 6.

Management guided Q2 revenue to $225–$240 million and holds a $2.2 billion backlog — signed work not yet recognized as revenue. Whether the stock stabilizes here or slides further likely hinges on whether that report shows the backlog converting into dollars, not just headlines.